Hepatitis C Elimination: England’s Progress and the Path Forward
England is making remarkable strides towards eliminating hepatitis C as a public health threat, with recent data revealing a significant 61.1% decline in chronic cases since 2015 – falling from 129,000 to approximately 50,200 in 2024. This progress is fueled by expanded testing programs and readily available, curative treatments.
The Impact of Targeted Testing and Treatment
The decline is particularly noticeable among people who inject drugs, a group at higher risk of infection. In 2024, only 5.2% of this population had hepatitis C, a dramatic decrease from 28.6% in 2015. This improvement highlights the effectiveness of targeted testing and treatment initiatives focused on those most vulnerable.
Hepatitis C is a viral infection that attacks the liver. Left untreated, it can lead to serious, life-threatening liver damage over many years. The virus spreads through blood-to-blood contact, making those who inject drugs, particularly those who share needles, especially susceptible.
NHS Home Testing: A Game Changer
The NHS has been a key driver of this success, with over 100,000 people utilizing the confidential home testing service since its launch in May 2023. This initiative has already saved an estimated 225 lives through early detection and treatment.
Did you grasp? More than 9 out of 10 cases of hepatitis C can be cured with a short course of antiviral tablets.
Addressing Remaining Challenges
Despite the positive trends, challenges remain. Approximately one in three people who inject drugs report inadequate access to clean needles and syringes. This underscores the need to strengthen harm reduction services and ensure equitable access to resources.
Dr. Monica Desai, Head of the Hepatitis Section at the UK Health Security Agency, emphasizes the importance of continued vigilance: “We are making significant progress towards eliminating hepatitis C. The sharp fall in cases since 2015 shows the impact of expanded testing and sustained access to modern curative treatments and the commitment of health services and community partners across England. While the number of people living with the virus continues to decline, it remains vital that those most at risk are offered testing, can access life-saving treatments, and receive the support needed to prevent new infections.”
The Role of Collaboration and Lived Experience
Rachel Halford, CEO of The Hepatitis C Trust, highlights the power of collaboration: “It is encouraging to see the continued commitment of the Government, the NHS, and partners driving a sustained reduction in cases of this treatable virus. This work is a shining example to the rest of our health system, and health systems around the world, that when you meaningfully involve all key stakeholders, including people with lived experience, in the design and delivery of services, you can achieve incredible things.”
Future Trends and Sustaining Progress
Looking ahead, sustaining this momentum requires a multi-faceted approach. Continued investment in testing, particularly among high-risk groups, is crucial. Strengthening harm reduction services, including needle exchange programs, will assist prevent new infections. Maintaining access to curative treatments and addressing health inequalities are essential for long-term success.
Pro Tip: If you think you may be at risk, don’t hesitate to get tested. Early detection is key to preventing serious health complications.
How to Get Tested
Hepatitis C testing is free and readily available through various channels:
- GPs
- Sexual health clinics
- Genitourinary medicine (GUM) clinics
- Drug treatment services
- NHS at-home finger-prick test
You can also assess your risk level by taking the Hepatitis C Trust Quiz.
Frequently Asked Questions
What are the symptoms of hepatitis C? Many people with hepatitis C have no symptoms, especially in the early stages. When symptoms do occur, they can be flu-like, including fatigue, nausea, and muscle aches.
Is hepatitis C curable? Yes, hepatitis C is curable in over 90% of cases with antiviral medications.
Who is at risk of hepatitis C? People who inject drugs, those who received blood transfusions before 1991, and individuals born to mothers with hepatitis C are at higher risk.
Where can I find more information? Visit the UK Health Security Agency website or The Hepatitis C Trust website for comprehensive resources.
What can I do to help? Share this information with your friends and family, and encourage anyone at risk to get tested.
